Experiences of postmenopausal osteoporosis: a narrative review

Abstract

Purpose A narrative review was conducted to identify, critically appraise, and synthesise primary research on the lived experiences of postmenopausal women with osteoporosis. Materials and methods A systematic search of qualitative studies published between January 1960 and August 2021 was conducted across seven databases. The selected qualitative studies reported the lived experiences of postmenopausal women with osteoporosis, both with and without a history of fragility fractures. Results A total of 17 publications (n = 334) were identified. These results suggest that osteoporosis and fragility fractures significantly affected postmenopausal women’s lives. They reported difficulties in carrying out daily activities due to pain and change in their routines to cope with health problems. Some women were satisfied with the information provided by healthcare professionals. Their medicine adherence was also determined by their belief in the importance of their scheduled treatment for osteoporosis. Conclusion Qualitative studies that explored the lived experiences of postmenopausal women with osteoporosis can provide important insights into the impact of the disease on women’s lives and potential pathways for improving care and management. Implications for rehabilitation Osteoporosis and fragility fractures affect the quality of life of postmenopausal women worldwide. The provision of targeted and tailored health information for postmenopausal women with osteoporosis is paramount in improving their health literacy and aiding in the long-term management of their bone health. What is already known Osteoporosis and related fragility fractures are common, affecting more than 200 million people worldwide, including three million people in the UK. Osteoporotic fractures have significant clinical and public health impacts. What this study adds Osteoporosis, particularly fragility fractures, has a significant impact on the lives of postmenopausal women, including pain and functional impairment. Women’s belief in the importance of their scheduled treatment plays a significant role in their concordance with the prescribed medications for osteoporosis. Provision of targeted health information for postmenopausal women with osteoporosis is key to their involvement in decision-making and disease management.